Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

TNF-alpha inhibitors can cause various immune-related skin issues.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

New cytokine-targeted therapies show promise for treating alopecia areata.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.